Comorbidities, Coinfections, & Complications
Active Resources: 24
-
In Valiant Vaccine Versus the Vicious Virus (Episode 1), Dr. MarkAlain Dery, an infectious disease physician, and Dr.
Type: Webinar RecordingsPublish Date: 7/26/2021 -
(Recorded June 24, 2021)
Type: Webinar RecordingsPublish Date: 7/6/2021 -
Training slides define and review isolated hepatitis B core antibody, isolated anti-HBc, occult HBV infection and the clinical significance, and HBV immunizations, and considerations
Type: Training MaterialsPublish Date: 5/10/2021 -
Training slides from a 2-part series on medication for type 2 diabetes in people with HIV.
Type: Training MaterialsPublish Date: 3/23/2021 -
Presentation/training slides cover the different methods of diagnosing diabetes and how they may not be accurate in people with HIV.
Type: Training MaterialsPublish Date: 12/23/2020 -
The slide set is for self-directed learning and downloadable for training purposes. The content addresses the following objectives:
Type: Training MaterialsPublish Date: 11/30/2020 -
Training slides covering lung cancer screening, practice patterns in hepatitis B vaccination, and heplisav B for people with HIV.
Type: Training MaterialsPublish Date: 11/13/2020 -
Training slides on oral HPV infections in people with HIV covering HPV pathogenesis, prevalence, risk factors, benign and malignant disorders, vaccines, and more.
Type: Training MaterialsPublish Date: 11/10/2020 -
Training slides discuss the role of direct oral anticoagulants in the management of atrial fibrillation and venous thromboembolism and the anticoagulation management guidelines, and
Type: Training MaterialsPublish Date: 10/30/2020 -
The National HIV Curriculum (NHC) offers free online continuing education for novice-to-expert health professionals, students, and faculty.
Type: Online and Self-Paced LearningPublish Date: 9/14/2020 -
State-specific resources to assist providers in navigating health coverage requirements that may impact the prescription of hepatitis c treatment.
Type: Clinical Reference ToolsPublish Date: 4/3/2020 -
The AETC National Coordinating Resource Center is maintaining this resource page for HIV providers seeking current COVID-19 information.
Type: Clinical Reference ToolsPublish Date: 3/20/2020Review Date: 7/1/2021 -
This toolkit includes webinars, online trainings and resources for both providers and patients such as:
Type: Clinical Reference ToolsPublish Date: 2/28/2020 -
The guidelines address the following opportunistic infections: PCP, Toxo, Cryptosporidia, Microsporidia, TB, MAC, Bacterial Respiratory Disease, Bacterial Enteric Disease, Bartonella, Syphilis, Can
Type: GuidelinesPublish Date: 3/18/2019Review Date: 2/11/2020 -
Comprehensive guidelines covering the epidemiology, diagnosis, and treatment of multiple opportunistic infections in children.
Contents:
Type: GuidelinesPublish Date: 2/8/2019 -
Northeast/Caribbean (NECA) AETC offers online continuing education accredited videos and monographs.
Type: Online and Self-Paced LearningPublish Date: 2/5/2019Review Date: 6/11/2021 -
The Hep C Free postcard is designed to celebrate and acknowledge patient success when hepatitis C viral suppression is achieved.
Type: Clinical Reference ToolsPublish Date: 5/31/2018Review Date: 11/29/2019 -
This multi-module curriculum is designed for specifically for Medical Case Managers.
Type: Training MaterialsPublish Date: 9/15/2017 -
Persons with human immunodeficiency virus (HIV) infection often develop complications related directly to the infection. This may also include its treatment.
Type: Articles, Reports, and ManualsPublish Date: 8/1/2017 -
Objectives
- List the recommended treatment regimens for mycobacterial infections (especially non-TB mycobacterial infections) among HIV-infected persons.
Type: Online and Self-Paced LearningPublish Date: 11/16/2016 -
First released in 2004, the Guide is a joint publication of CITC and the Tuberculosis Control Branch of the California Department of Public Health.
Type: Articles, Reports, and ManualsPublish Date: 10/25/2016Review Date: 4/23/2021 -
Objectives
- Describe the financial impact of HCV treatment
Type: Online and Self-Paced LearningPublish Date: 10/19/2016Review Date: 6/18/2021 -
Objectives
- List available HCV direct acting antivirals (DAAs) available for HCV therapy in 2016
- Describe appropriate HCV DAA therapies for HCV genotypes
Type: Online and Self-Paced LearningPublish Date: 10/12/2016 -
Developed by the AETC Mental Health Committee for the Integrating Mental Health and Substance Use Care into HIV Primary Care Toolkit
Type: Clinical Reference ToolsPublish Date: 6/2/2015Review Date: 5/17/2019
Archive Resources: 7
-
Type: Online and Self-Paced LearningPublish Date: 2/1/2017
-
Type: Articles, Reports, and ManualsPublish Date: 1/1/2017Review Date: 4/20/2021
-
Objectives
- Identify issues associated with treating older individuals with HIV infection
Type: Online and Self-Paced LearningPublish Date: 12/7/2016 -
Objectives
- Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
Type: Online and Self-Paced LearningPublish Date: 10/26/2016 -
36 evidence-based recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treatment coverage, retention in care, and vira
Type: GuidelinesPublish Date: 11/9/2015 -
This Policy Brief is a follow-up document to the 2011 WHO document, "Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender pe
Type: Articles, Reports, and ManualsPublish Date: 8/27/2015 -
M
Type: Clinical Reference ToolsPublish Date: 1/31/2014
Articles: 2
-
HIV and Heart Disease – NIH Explores the Connection
HIV-positive men and women can now live longer than ever before. A 2013 study found that a newly diagnosed 20 year old on effective antiretroviral therapy (ART) can expect to live into their 70s. A lifespan only slightly lower than in people without HIV.[1] While this is great news, physicians...
-
Use of Dolutegravir in Dialysis
Dolutegravir has several characteristics that, in theory, suggest it will not be significantly removed by dialysis: It has a large apparent volume of distribution (17.4 L) and is highly protein bound (98.9%). A small study of 5 HIV-infected patients with end-stage renal disease...
-
Aug 4Pangenotypic Regimens for HCVEvent type: Webinars
-
Jul 25